Gabor Mohos

Gabor Mohos

Auto-generated profile, based on publicly available information

Gabor Mohos

Department of Radiology, Medical Imaging Centre, Semmelweis University 1082 Budapest, Korányi Sándor street 2., Hungary

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2019 in Bőrgyógyászati és Venerológiai Szemle
Verified
Journal Article
Open access
JVJános Varga
János Varga
DSDepartment of Dermatology and Allergology Albert Szent-Györgyi Medical Center University of Szeged
Department of Dermatology and Allergology Albert Szent-Györgyi Medical Center University of Szeged
BBBalázs Bende
Balázs Bende
AAAnita Altmayer
Anita Altmayer
MGMagdolna Gaál
Magdolna Gaál
Lajos KeményLajos Kemény
Lajos Kemény

26 June 2025 in Imaging
Verified
Journal Article
Open access
PDF file
GMGabor Mohos
Gabor Mohos
AFAdam Zoltan Farkas
Adam Zoltan Farkas
ABAndrás Bibok
András Bibok
DKDavid Adam Korda
David Adam Korda
OHOszkar Hahn
Oszkar Hahn
DHDenes B. Horvathy
Denes B. Horvathy
We report a case of a female patient in her 40s who presented with right upper quadrant pain and abdominal discomfort. Surgical removal was not possible due to the location of the lesion. Between 2021 and 2022, the patient had four additional sessions of conventional transarterial embolization (TAE) with Lipiodol, but none succeeded in sufficiently reducing the hemangioma's size or permanently improving the symptoms. In November 2022, we used transarterial chemoembolization (TACE) with a Bleomycin-Lipiodol emulsion. Follow-up MRI scans showed a gradual reduction in the hemangioma volume, but the symptoms only improved partially. Hence, the patient underwent a second bleomycin TACE embolization in November 2023. By August 2024, control showed a total volume reduction of 409 cm³ (56%) and significant symptom improvement. This case demonstrates that Bleomycin-Lipiodol TACE can effectively reduce the size of giant liver hemangiomas, even after the failure of other interventional therapies.


26 June 2025 in Imaging
Verified
Journal Article
Open access
PDF file
GMGabor Mohos
Gabor Mohos
AFAdam Zoltan Farkas
Adam Zoltan Farkas
ABAndrás Bibok
András Bibok
DKDavid Adam Korda
David Adam Korda
OHOszkar Hahn
Oszkar Hahn
DHDenes B. Horvathy
Denes B. Horvathy
"Addendum to: Successful treatment of a therapy-resistant, giant liver hemangioma with repeated bleomycin TACE: A case report" published on 06 May 2025 by Akadémiai Kiadó.